GoHealth Q1 2024 Adj EPS $(0.85) Beats $(0.95) Estimate, Sales $185.600M Beat $180.154M Estimate
Portfolio Pulse from Benzinga Newsdesk
GoHealth (NASDAQ:GOCO) reported Q1 2024 adjusted EPS of $(0.85), surpassing the $(0.95) estimate, with sales of $185.6M exceeding the $180.154M forecast, marking a 1.33% year-over-year increase.
May 09, 2024 | 10:09 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GoHealth reported Q1 2024 earnings with better-than-expected adjusted EPS and sales, indicating a positive performance against analyst estimates.
Beating both EPS and sales estimates typically leads to a positive short-term reaction in the stock market as it indicates the company is performing better than analysts expected. The year-over-year sales growth further strengthens the company's financial position and market perception.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100